Molecular signatures of sanguinarine in human pancreatic cancer cells: A large scale label-free comparative proteomics approach.

Singh, Chandra K; Kaur, Satwinderjeet; George, Jasmine; Nihal, Minakshi; Pellitteri Hahn, Molly C; Scarlett, Cameron O; Ahmad, Nihal

Singh, Chandra K; Kaur, Satwinderjeet; George, Jasmine; Nihal, Minakshi; Pellitteri Hahn, Molly C; Scarlett, Cameron O; Ahmad, Nihal.

Affiliation

Singh CK; Department of Dermatology, University of Wisconsin, Madison, WI, USA.
Kaur S; Department of Dermatology, University of Wisconsin, Madison, WI, USA.
George J; Department of Dermatology, University of Wisconsin, Madison, WI, USA.
Nihal M; Department of Dermatology, University of Wisconsin, Madison, WI, USA.
Pellitteri Hahn MC; School of Pharmacy, University of Wisconsin, Madison, WI, USA.
Scarlett CO; School of Pharmacy, University of Wisconsin, Madison, WI, USA.
Ahmad N; Department of Dermatology, University of Wisconsin, Madison, WI, USA.

Oncotarget ; 6(12): 10335-48, 2015 Apr 30.

Article de En | MEDLINE | ID: mdl-25929337

Sujet(s)
Mots clés

DUSP4; chemoprevention; pancreatic cancer; quantitative proteomics; sanguinarine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Tumeurs du pancréas / Benzophénanthridines / Isoquinoléines Type d'étude: Prognostic_studies Limites: Humans Langue: En Journal: Oncotarget Année: 2015 Type de document: Article Pays d'affiliation: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google